Drug Price Transparency
Drug Price Transparency organizes records from CMS data API into a static table for transparent comparison. It preserves official source links and dates, marks missing enrichment, and adds deterministic grouping, change, recency, trend, or significance fields only where the documented inputs support them, without recommendations or unsupported claims.
| Record | Record Date | Vuga Group | Change Status | Recency Days | Public Significance Score |
|---|---|---|---|---|---|
| Glucagon Emergency Kit | 01/01/2024 | Glucagon | increased | 972.23 | 100 |
| Glucagon Emergency Kit | 01/01/2024 | Glucagon | increased | 972.23 | 100 |
| Granix | 01/01/2024 | Tbo-Filgrastim | increased | 972.23 | 100 |
| Granix | 01/01/2024 | Tbo-Filgrastim | increased | 972.23 | 100 |
| Gvoke Hypopen 1-Pack | 01/01/2024 | Glucagon | increased | 972.23 | 100 |
| Gvoke Hypopen 1-Pack | 01/01/2024 | Glucagon | increased | 972.23 | 100 |
| Gvoke Hypopen 2-Pack | 01/01/2024 | Glucagon | increased | 972.23 | 100 |
| Gvoke Hypopen 2-Pack | 01/01/2024 | Glucagon | increased | 972.23 | 100 |
| Gvoke PFS 1-Pack Syringe | 01/01/2024 | Glucagon | increased | 972.23 | 100 |
| Gvoke PFS 1-Pack Syringe | 01/01/2024 | Glucagon | increased | 972.23 | 100 |
| Gvoke PFS 2-Pack Syringe | 01/01/2024 | Glucagon | increased | 972.23 | 100 |
| Gvoke PFS 2-Pack Syringe | 01/01/2024 | Glucagon | increased | 972.23 | 100 |
| Gvoke | 01/01/2024 | Glucagon | increased | 972.23 | 100 |
| Gvoke | 01/01/2024 | Glucagon | increased | 972.23 | 100 |
| Hadlima Pushtouch | 01/01/2024 | Adalimumab-Bwwd | increased | 972.23 | 100 |
| Hadlima Pushtouch | 01/01/2024 | Adalimumab-Bwwd | increased | 972.23 | 100 |
| Hadlima(Cf) Pushtouch | 01/01/2024 | Adalimumab-Bwwd | increased | 972.23 | 100 |
| Hadlima(Cf) Pushtouch | 01/01/2024 | Adalimumab-Bwwd | increased | 972.23 | 100 |
| Hadlima(Cf) | 01/01/2024 | Adalimumab-Bwwd | increased | 972.23 | 100 |
| Hadlima(Cf) | 01/01/2024 | Adalimumab-Bwwd | increased | 972.23 | 100 |
| Hadlima | 01/01/2024 | Adalimumab-Bwwd | increased | 972.23 | 100 |
| Hadlima | 01/01/2024 | Adalimumab-Bwwd | increased | 972.23 | 100 |
| Haegarda | 01/01/2024 | C1 Esterase Inhibitor | increased | 972.23 | 100 |
| Haegarda | 01/01/2024 | C1 Esterase Inhibitor | increased | 972.23 | 100 |
| Halaven | 01/01/2024 | Eribulin Mesylate | increased | 972.23 | 100 |
| Halaven | 01/01/2024 | Eribulin Mesylate | increased | 972.23 | 100 |
| Harvoni | 01/01/2024 | Ledipasvir/Sofosbuvir | increased | 972.23 | 100 |
| Harvoni | 01/01/2024 | Ledipasvir/Sofosbuvir | increased | 972.23 | 100 |
| Heplisav-B | 01/01/2024 | Hepatitis B Vaccine/Cpg1018/PF | increased | 972.23 | 100 |
| Heplisav-B | 01/01/2024 | Hepatitis B Vaccine/Cpg1018/PF | increased | 972.23 | 100 |
| Herceptin Hylecta | 01/01/2024 | Trastuzumab-Hyaluronidase-Oysk | increased | 972.23 | 100 |
| Herceptin Hylecta | 01/01/2024 | Trastuzumab-Hyaluronidase-Oysk | increased | 972.23 | 100 |
| Herceptin | 01/01/2024 | Trastuzumab | increased | 972.23 | 100 |
| Herceptin | 01/01/2024 | Trastuzumab | increased | 972.23 | 100 |
| Herzuma | 01/01/2024 | Trastuzumab-Pkrb | increased | 972.23 | 100 |
| Herzuma | 01/01/2024 | Trastuzumab-Pkrb | increased | 972.23 | 100 |
| Hetlioz Lq | 01/01/2024 | Tasimelteon | increased | 972.23 | 100 |
| Hetlioz Lq | 01/01/2024 | Tasimelteon | increased | 972.23 | 100 |
| Hetlioz | 01/01/2024 | Tasimelteon | increased | 972.23 | 100 |
| Hetlioz | 01/01/2024 | Tasimelteon | increased | 972.23 | 100 |
| Hulio(Cf) Pen | 01/01/2024 | Adalimumab-Fkjp | increased | 972.23 | 100 |
| Hulio(Cf) Pen | 01/01/2024 | Adalimumab-Fkjp | increased | 972.23 | 100 |
| Hulio(Cf) | 01/01/2024 | Adalimumab-Fkjp | increased | 972.23 | 100 |
| Hulio(Cf) | 01/01/2024 | Adalimumab-Fkjp | increased | 972.23 | 100 |
| Humatin | 01/01/2024 | Paromomycin Sulfate | increased | 972.23 | 100 |
| Humatin | 01/01/2024 | Paromomycin Sulfate | increased | 972.23 | 100 |
| Humatrope | 01/01/2024 | Somatropin | increased | 972.23 | 100 |
| Humatrope | 01/01/2024 | Somatropin | increased | 972.23 | 100 |
| Humira Pen | 01/01/2024 | Adalimumab | increased | 972.23 | 100 |
| Humira Pen | 01/01/2024 | Adalimumab | increased | 972.23 | 100 |